Publikationen als Erst und Co-Autor.
Aus Datenschutzgründe und fehlende Einverständnis- Erklärung werden die Co-Autoren in der Liste nicht angeführt. Namentliche Ergänzungen sind nach Wünsch der CO-Autoren mit schriftlicher Zustimmung möglich
Mehrabi M.Reza. Gefässverschluss, rechtzeitige Diagnose kann Leben retten People,I/2008
Mehrabi M.Reza. Lymphödem, Jatros Dermatologie, 1/2008, Seite 6-9
Mehrabi M.Reza. Lymphödem, Jatros Diabetes und Stoffwechsel, 1/2008, Seite 6-10
Mehrabi MR et all: Clinical benefit of prostaglandin E1-treatment of patients with ischemic heart disease: stimulation of therapeutic angiogenesis in vital and infarcted myocardium.
Biomed Pharmacother. 2003; 57:173-8.
Mehrabi MR et all: The melatonin receptor subtype MT2 is present in the human cardiovascular system. J Pineal Res. 2003; 35:40-44.
Mehrabi MR et all: Revascularization of myocardial scar tissue following prostaglandin E1-therapy in patients with ischemic heart disease. Pathol Res Pract. 2003; 199:129-36.
Mehrabi MR et all: Elevated homocysteine serum level is associated with low enrichment of homocysteine in coronary arteries of patients with coronary artery disease. Thromb Res. 2002; 107:189-96.
Mehrabi MR et all: The arylhydrocarbon receptor (AhR), but not the AhR-nuclear translocator (ARNT), is increased in hearts of patients with cardiomyopathy. Virchows Arch. 2002; 441:481-9. Epub 2002 Jun 27.
Mehrabi MR et all: The peroxisome proliferator-activated receptor gamma (PPARgamma) is highly expressed in human heart ventricles. Biomed Pharmacother. 2002; 56:407-10.
Mehrabi MR et all: Clinical and experimental evidence of prostaglandin E1-induced angiogenesis in the myocardium of patients with ischemic heart disease. Cardiovasc Res. 2002; 56:214-24.
Mehrabi MR et all: Enhanced accumulation of the isoprostane, 8-epi-PGF2 alpha, in human aortic and pulmonary valves of patients with coronary heart disease. Histol Histopathol. 2002; 17:1053-9.
Mehrabi MR et all: 24h variation in the expression of the mt1 melatonin receptor subtype in coronary arteries derived from patients with coronary heart disease. Chronobiol Int. 2001; 18:973-85 .
Mehrabi MR et all; Expression of the MT1 melatonin receptor subtype in human coronary arteries. J Recept Signal Transduct Res. 2001; 21:85-91.
Mehrabi MR et all:The isoprostane 8-epi-PGF(2alpha) is a valuable indicator of oxidative injury in human heart valves. Cardiovasc Pathol. 2001; 10:241-5.
Mehrabi MR et All: Angiogenesis stimulation in explanted hearts from patients pre-treated with intravenous prostaglandin E1. J Heart Lung Transplant. 2001; 20:465-73.
Mehrabi MR et all: Oxidized low-density lipoprotein is localized in the ventricles of hearts from patients with coronary heart disease. Int J Clin Lab Res. 2000; 30:133-40.
Mehrabi MR et all: Accumulation of oxidized LDL in human semilunar valves correlates with coronary atherosclerosis. Cardiovasc Res. 2000; 45:874-82.
Mehrabi MR et all: The isoprostane, 8-epi-PGF2 alpha, is accumulated in coronary arteries isolated from patients with coronary heart disease.
Cardiovasc Res. 1999; 43:492-9.
Mehrabi MR et all: Wiener Klin Wochenschr. 1999 ;111:113-8.
Mehrabi M et all: Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT: correlation with histopathology in explanted hearts. J Am Coll Cardiol. 1998; 32:1701-8.
Mehrabi MR et all; Expression of fibrinolytic antigens in redistributed cardiac mast cells in auricular thrombosis. Hum Pathol. 1997; 28:1283-90.
Mehrabi MR et all: Thrombin augments vascular cell-dependent migration of human mast cells: role of MGF.Thromb Haemost. 1997 ;77:577-84.
Mehrabi M: Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis.
Am J Cardiol. 1995; 75:913-8.
Mehrabi M et all: Endomyocardial HLA expression is increased to the same extent in idiopathic and secondary dilated cardiomyopathy. Immunol Lett. 1994; 41:59-66.
Mehrabi M et all: Serum-soluble CD4 as clinical and immunological marker in patients with dilated cardiomyopathy. Immunol Lett. 1993; 38:103-9.
Book Reviews
Aus Datenschutzgründe und fehlende Einverständnis- Erklärung werden die Co-Autoren in der Liste nicht angeführt. Namentliche Ergänzungen sind nach Wünsch der CO-Autoren mit schriftlicher Zustimmung möglich
Mehrabi MR et all: Prostaglandin E1 Induces Neovascularization in Explanted Hearts Derived from Patients with Idiopathic Dilated Cardiomyopathy. Coronary Artery Disease. Prevention to Intervention, Monduzzi editore, International Proceedings Division, 2000; 241-246
Mehrabi MR et all: Isoprostane, 8-epi-PGF2α, Accumulates in Human Aortic and Pulmonary Valves of Patients with Dilative Cardiomyopathy Coronary Artery Disease. Prevention to Intervention, Monduzzi editore, International Proceedings Division, 2000; 347-352
Mehrabi MR et all: Coronary Heart Disease Is Associated with Enhanced Accumulation of the Isoprostane, 8-epi-PGF2α, in Human Aortic and Pulmonary Valves Coronary Artery Disease. Prevention to Intervention, Monduzzi editore, International Proceedings Division, 2000; 241-246
Mehrabi MR et all: Homocysteine – An Essential Substrate in Coronary Artery Metabolism – an Immunohistochemical Coronary Artery Disease. Prevention to Intervention, Monduzzi editore, International Proceedings Division, 2000; 359-364
Mehrabi MR et all: Lymphangiogenesis and Denervation after Transmyocardial Laser Revascularization in Human Hearts – Clinical Consequences. Coronary Artery Disease.
Prevention to Intervention, Monduzzi editore, International Proceedings Division, 2000; 259-262
Mehrabi MR et all: Overexpression of Neural Cell Adhesion Molecule (CD 56) in Hibernating Myocardium Coronary Artery Disease.
Prevention to Intervention, Monduzzi editore, nternational Proceedings Division, 2000; 209-212
ABSTRACTS
Aus Datenschutzgründe und fehlende Einverständnis- Erklärung werden die Co-Autoren in der Liste nicht angeführt. Namentliche Ergänzungen sind nach Wünsch der CO-Autoren mit schriftlicher Zustimmung möglich
MR. Mehrabi et all: Prostaglandine E1-Treatment stimulates angiogenesis in patients with
chronic ischemic heart disease. Österreichische Kardiologische Gesellschaft, Linz 2001.
MR Mehrabi et all: Elevated Homocysteine serum level is associated with low enrichment of homocysteine in coronary arteries of patients with coronary heart disease.
Österreichische Kardiologische Gesellschaft, Linz 2001.
MR. Mehrabi et all; Prostaglandine E1 induce endothelial proliferation in explanted hearts derived from patients with ischemic cardiomyopathy. 4th Intern. Congress on Coronary Artery Disease, Prague, 2001
MR. Mehrabi et all: Prostaglandine E1 induce expression of VEGF and stimulate neoangiogenesis in patients with ischemic cardiomyopathy. 4th Intern. Congress on Coronary Artery Disease, Prague, 2001
MR. Mehrabi et all: Prostaglandine E1 increase degree of reparative fibrosis in patients with ischemic cardiomyopathy. 4th Intern. Congress on Coronary Artery Disease, Prague, 2001
MR. Mehrabi et all: Immunohistochemical evidence of homocysteine enrichment in human valves of patients with ischemic cardiopathy. 4th Intern. Congress on Coronary Artery Disease, Prague, 2001
Mehrabi MR et all: PGE1 stimuliert die Neoangiogenese in Herzen von Patienten mit idiopatischer dilatativer Kardiomyopathie (IDCM) J Kardiol; 7 (6): 257 (2000); Jahrestagung der Österreichischen Kardiologischen Gesellschaft
Mehrabi MR et all: Enhanced accumulation of the isoprostane, 8-epi-PGF2α, in human aortic and pulmonary valves of patients with coronary heart disease.
German J Cardiol.; 89 (9): 889; Update in Thrombolysis, Vienna, 2000
Mehrabi MR et all: Stimulation of angiogenesis with prostaglandine in human hearts in patients with dilated cardiomyopathy. German J Cardiol.; 89 (9): 889; Update in Thrombolysis, Vienna, 2000
Mehrabi MR et all: Homocysteine – an essential substrate in coronary artery metabolism?
German J Cardiol.; 89 (9): 898; Update in Thrombolysis, Vienna, 2000
Mehrabi MR et all: Isoprostane-8 epi-PGF2α, accumulates in human aortic and pulmonary valves of patients with dilative cardiomyopathy
3rd International Congress on CAD from Prevention to Intervention, Lyon, France, 2000; P. 29 Mehrabi MR et all: Neural Cell Adhesion Molecule (NCAM) – Expression im ischämischen Myokard J Kardiol; 7 (6): 275 (2000); Jahrestagung der Österreichischen Kardiologischen Gesellschaft
Mehrabi MR et all: Ist Homocystein ein Risikofaktor für die koronare Herzkrankheit? – Eine immunhistochemische Neubewertung. Acta Chir Austiaca; 32 (162): 23(2000); 41. Jahrestagung der Österreichischen Gesellschaft für Chirurgie.
Mehrabi MR et all: Modulated expression of neural cell adhesion molecule (CD 56) in ischemic myocardium. German J Cardiol.; 89 (9): 889; Update in Thrombolysis, Vienna, 2000
Mehrabi MR et all: Coronary heart disease is associated with enhanced accumulation of the isoprostane 8-epi-PGF2a in human aortic and pulmonary valves.
3rd International Congress on CAD from Prevention to Intervention, Lyon, France, 2000, P 29
Mehrabi MR et all : Homocysteine – an essential substrate in coronary artery metabolism – an immunohistochemical study.
3rd International Congress on CAD from Prevention to Intervention, Lyon, France, 2000; P. 153
Mehrabi MR et all: Prostaglandine induce neovascularization in patients with therapy refractory ischemic heart disease.
3rd International Congress on CAD from Prevention to Intervention, Lyon, France, 2000; P. 169
Mehrabi MR et all: Lymphangiogenesis and denervation after transmyocardial laser revascularization in human hearts – clinical consequences.
3rd International Congress on CAD from Prevention to Intervention, Lyon, France, 2000; S. 127
Mehrabi MR et all:. Overexpression of neural cell adhesion molecule (CD 56) in hibernating myocardium
3rd International Congress on CAD from Prevention to Intervention, Lyon, France, 2000; P. 48
Mehrabi MR et all: correlates with TUNEL-stained area in human ischemic myocardium.
3rd Symposium on Cytokines and Apoptosis in the Cardiovascular System, Halle; Jan. 2000
M.R. Mehrabi et all: Stimulation of angiogenesis and inhibition of fibrosis in explanted hearts from patients with dilated cardiomyopathy pretreated with PGE 1. Öster. kardiologische Geselschaft, Gmunden, 31.5.-3.6.2000
M.R. Mehrabi et all: Stimulation of angiogenesis and inhibition of fibrosis in explanted hearts from patients with dilated cardiomyopathy pretreated with PGE 1. Austrian society for endokrinology and metabolism, April 27-29, 2000. Austria, St.Wolfgang, DIA Presentation
M.R. Mehrabi et all: Stimulation of angiogenesis in explanted heart from patients pretred with intravenous prostaglandin E 1.
20th Annual Meeting and Scientific Sessions, April 5-8, 2000. Osaka, Japan
M.R. Mehrabi et all: Stimulation of angiogenesis and inhibition of fibrosis in explanted hearts from patients with dilated cardiomyopathy pretreated with PGE 1.
2nd Annual meeting of the Austrian Vascular Biology Organization, 5.11.99, Vienna, Austria, 5.11.99
M.R. Mehrabi et all: Oxidized LDL is accumulating in semilunar valves of patients with coronary atherosclerosis. 2nd Annual meeting of the Austrian Vascular Biology Organization, 5.11.99, Vienna, Austria, 5.11.99
M.R. Mehrabi et all: Accumulation of oxidized LDL in human semilunar valves correlates with coronary atherosclerosis
Cor europaeum,European Journal for Cardiac Internations, Vol. 8, No. 1/1999
M.R. Mehrabi et all: Accumulation of oxidized-LDL in human semilunar valves correlates with coronary atherosclerosis
Anual EVBA Meeting 99, May 13-16th 1999, Baden, Austria
M.R. Mehrabi et all: The isoprostane, 8-epi-PGF2α, is accumulated in coronary arteries by patients with heart disease.
Annual EVBA Meeting 99, May 13-16th 1999, Baden, Austria
M.R. Mehrabi et all: Expression of a Receptor for environmental Toxins in The human Myocard: transcription factor Arylhydrocarbon receptor (AhR) and hypoxia-Inducible factor 1 beta (HIF-ß1). American euro date, June 7- 11, 1999, Vienna, Austria
M.R. Mehrabi et all: The isoprostane, 8-epi-PGF2α, is accumulated in coronary arteries isolated from patients with coronary heart disease.
Symposium Biomedizinische Forschung im AKH, 23.4.1999, Wien
M.Mehrabi et all: Preliminary Data on Detection of Oxidation- Derived Epitopes on Human Native and Ischemic Coronaries.
Annual EVBA Meeting 99, May 13-16th 1999, Baden, Austria
M. Mehrabi et all: Pharmacological and non- Pharmacological factors influencing myocardial 123i- MIBG-uptake in – vitro studies on human and experimental rabbit cardiac tissue.
The 9th Mediterranean Meeting, Lemesos- Akamas, Cyprus, May 13-17, 1999
M. Mehrabi et all: Immunohistochemical determination of isoprostanes in human coronaryarteries, A-comparison with immunoassaying. 11th Meeting of the Danubian league against Thrombosis and Hemorrhagic disorders.
Frankfurt a.M., Germany October 1-3,1998
M. Mehrabi et all: Immunohistochemical and radioimmunological evidence for human coronary artery oxidation injury in coronary heart disease.
XXth Congress of the EuropeanSociety of Cardiolotgy.August 22-26, 1998,Vienna, Austria
M. Mehrabi et all: Immunohistochemical determination of 8-epi-prostaglandin F2alpha in human arteries. XIII International Symposium on drugs affecting,Lipid metabolism.
Florence,May 30-june 3, 1998
Mehrabi M. et all: Expression of fibrinolytic antigens in redistributed mast cells in auricular thrombosis.
Mehrabi M.R et all: demonstration of increase cyclin D- 1 expression of cyclin dependent kinase 4 positive cells in ischemic cardiomyopathy.
XIII World Congress of Cardiology, April 26-30, 1998, Rio de janerio, Brazil
Mehrabi M et all: Erweiterte Aussage -Möglichkeiten bei der Myokardaktivität durh kombinierte Anwendung von Dobutaminecho und Thaliumszitigraphie – Histopathologische evaluidierung. ÖKG, Jahrestagung. 11. Bis 13. Juni 1998 in Gmunden
Mehrabi M. et all: Diagnostic and Prognostic Value of Soluble Interleukin 2 Receptor in the Serum of Patients With Idiopathic or Ischemic Dilated Cardiomyopathy.
J Am Coll Cardiol 1997.
Mehrabi M.R et all: Thrombin Augments Vascular Cell- Dependent Migration of Human Mast Cells: Rle of Mast Cell Growth Factor. Thromb. & Haemost. 77(3) 577- 584 (1977)
Mehrabi M.R et all: Thrombin Upregltes Endothelial Cell- Depenent Migration of Human Mast Cells. Rolle of MGF.
Deutschen und Österreichi. Gesellschaft für Hämatologie und Onkologie Linz, 12-15 Okt.1997
Mehrabi M. et all: Increased Platelet Derived Endothlial Cell Growth factor(PDECGF) Expression in Ischemic myocardium. 1st International congress on Coronary Artery Disease. Prag, September 21-24,1997
Mehrabi M. et all: Isoprostane 8-epi 2a and 6-keto PGF1a in Normal and atherosclerotic vascular Tissue. 20-24 July 1997, Edinburgh, Scotland
Mehrabi M. et all: Elevated Plasma Levels of C- Reactive Protein are Predictors of Late Restenosis After Coronary Angioplasty. Fibrinolysis 1996, 10(suppl): 54
Mehrabi M. et all: THROMBIN AUGMENTS VASCULAR CELL – DEPENDENT MIGRATION OF MAST CELLS AND EXPRESSION OF SCF.
Mehrabi M. et all: Vascular cell dependent migration of human mast cells is mediated by c-kit ligand and augmentable by thrombin Second Meetig of the European Haematology Association May 29-June 1,1996 Paris, France
Mehrabi M et all: Discrepancies Between Dobutamine Echo and Thalium Scintigraphy in Assessing Myocardial Viability. New Insights From Histopatholgic Correlations in Explanted Hearts
Mehrabi M. et all: Assessment of Myocardial Viablity by Dobutamine Echocardiography: Histopathologic Correlaiton in Explanted Hearts.
Supplement I Circulaiton Vol 92, No 8; October 15, 1995
Mehrabi M. et all: Immunohistochemical Localization of Growth Factorsin the Human Failing Myocardium. Am. college of Cardiology .1995, 22: 91A-92A
Mehrabi M. et all: Erhöhte Plasmaspiegel von C -reaktivem Protein (CRP) sind Prädiktoren einer späten Restenose nach nach Koronargefäßdilatation
61.Jahrestagung der Deut. Ges. für Kardiologie -Herz-und Kreislaufforschung
20. – 22. April 1995 Mannheim, Deutschland
Mehrabi M et all: Predominance of CD4-positive cells among activated T-lymphocytes in the human failing heart. Circulation 1993; 88: I-541.
Mehrabi M. et all: Increased content of beta 2-microglobulin in the human failing heart. Circulation 1993;88:I-540.
Mehrabi M. et all: Demonstration of reversed IL-7R/IL-2R expression on CD3+ TIL toward IL-2R with increasing proximity to malignant prostatic cells.
FASEB Experimental Biology. March 28-April 1,1993, New Orleans, Lousiana, USA
Mehrabi M. et all: HCG, hCGß, hCGß core fragment and hCGa in serum, urine and hydrocele fluid of testicular cancer (TC) patients Cycloprotein Hormones: Structure, Function and Clinical Implications. March 11-14, 1993, Santa Barbara, California,USA